The real-life experience of vedolizumab efficacy and safety in Crohn's disease: a prospective observational multicentre cohort study - Archive ouverte HAL Accéder directement au contenu
Communication Dans Un Congrès Année : 2016

The real-life experience of vedolizumab efficacy and safety in Crohn's disease: a prospective observational multicentre cohort study

(1) , (2) , (3) , (4) , (5) , (6) , (7) , (8, 9) , (10) , (11) , (12) , (13) , (14) , (15) , (16) , (17) , (18) , (19) , (20) , (21) , (22)
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
Bruno Bonaz
  • Fonction : Auteur
Fichier non déposé

Dates et versions

hal-03553395 , version 1 (02-02-2022)

Identifiants

  • HAL Id : hal-03553395 , version 1

Citer

Aurélien Amiot, Jean-Charles Grimaud, Xavier Treton, Jérôme Filippi, Benjamin Pariente, et al.. The real-life experience of vedolizumab efficacy and safety in Crohn's disease: a prospective observational multicentre cohort study. 11. Congress of ECCO, European Crohn’s and Colitis Organisation, Mar 2016, Amsterdam, Netherlands. ⟨hal-03553395⟩
15 Consultations
0 Téléchargements

Partager

Gmail Facebook Twitter LinkedIn More